Market Overview

Self-Monitoring Blood Glucose Devices: Worldwide Trends, Drivers, Restraints and Opportunities to 2023

Share:

Self-Monitoring Blood Glucose Devices: Worldwide Trends, Drivers, Restraints and Opportunities to 2023

PR Newswire

DUBLIN, July 31, 2018 /PRNewswire/ --

The "Self-Monitoring Blood Glucose Devices Market by Type, by Application, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013 - 2023" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Global self-monitoring blood glucose devices market size is forecasted to reach $18.6 billion by 2023.

This growth in the market is attributed to the increasing prevalence of diabetes, surge in geriatric population, and technological advancements. Moreover, increasing awareness about diabetic care, rising obese population, and favorable in health insurance and reimbursement scenario are also driving the growth of the market, globally.

On the basis of type, the self-monitoring blood glucose devices market is categorized into strips, glucose meters, lancets and others. Among all types, strips held the largest share in the market, accounting for more than 80% contribution in 2017.

Self-monitoring blood glucose devices are mainly used for monitoring type 1 and type 2 diabetes. Between the two, the use of self-monitoring blood glucose devices is expected to exhibit faster growth for monitoring type 2 diabetes, with a CAGR of 6% during the forecast period. This is attributed to the rising prevalence of type 2 diabetes among adults, which is substantiated from the fact that, among all diabetes cases, 90% to 95% of the cases are found to be suspected with type 2.

Some of the risk factors of type 2 diabetes include increasing geriatric population, family history of diabetes, impaired glucose tolerance, and obesity and physical inactivity. Moreover, ethnicity is also a risk factor for the occurrence of type 2 diabetes. African Americans, American Indians, Hispanic/Latino Americans, and some Asian Americans and Pacific Islanders have high probability of developing type 2 diabetes.

The market is projected to witness the fastest growth in APAC

During the forecast period, the self-monitoring blood glucose devices market is projected to witness the fastest growth in Asia-Pacific (APAC), with a CAGR of 7.0%. This can be attributed to the increasing prevalence of type 2 diabetes, surging geriatric population, and government spending on healthcare in the region. According to the International Diabetes Federation (IDF), in 2017, around 82 million of adults (20-79 years) were found to be suspected with diabetes in Southeast Asia, constituting a prevalence of 8.5% in the region; of those, around 45.8% were undiagnosed.

In addition, rising awareness about diabetes and its complications such as, delayed wound healing and diabetic foot ulcer) is also accelerating the growth of self-monitoring blood glucose devices market in the region. For instance, in October 2018, IDF has announced to organize an event titled as IDF Diabetes Complications and Foot Congress 2018, in Hyderabad, India. The event would provide information diabetes and complications associated with it, along with its management.

Key players are launching new products to increase their market share

Key players are launching various products in the self-monitoring blood glucose devices industry to increase their market share. For instance, in August 2017, Nova Biomedical launched the CE-Marked critical care analyzer, Stat Profile Prime Plus, for improving the testing standards. It provides 22 essential critical care tests that include blood gases, electrolytes, metabolites, hematology, and co-oximetry. Prime Plus also features new and patented, non-lysing whole blood co-oximetry technology, along with automated quality control (QC), powerful data management, bidirectional connectivity, and extensive cybersecurity protection.

Besides, in July 2017, Bionime Corporation launched the Rightest Bluetooth Glucose Meter - GM700SB, in Taiwan. It is linked with Rightest CARE App that allows consumers to record the multi-dimensional information such as photo upload, diet log, and dose of insulin usage. Diabetic patients can easily predict the blood glucose change and structured blood glucose information with the use of this meter.

Some of the other key players (other than those mentioned above) operating in the self-monitoring blood glucose devices market are Johnson & Johnson, Sinocare Inc., ARKRAY Inc., Medtronic plc, B. Braun Melsungen AG, Abbott Laboratories, and Bayer AG.

Key Topics Covered

Chapter 1. Research Background


1.1 Research Objectives


1.2 Market Definition


1.3 Research Scope


1.3.1 Market Segmentation By Type


1.3.2 Market Segmentation By Application


1.3.3 Market Segmentation By Geography


1.3.4 Analysis Period


1.3.5 Market Data Reporting Unit


1.3.5.1 Value


1.4 Key Stakeholders



Chapter 2. Research Methodology


2.1 Secondary Research


2.2 Primary Research


2.2.1 Breakdown Of Primary Research Respondents


2.2.1.1 By Region


2.2.1.2 By Industry Participant


2.2.1.3 By Company Type


2.3 Market Size Estimation


2.4 Data Triangulation


2.5 Assumptions For The Study



Chapter 3. Executive Summary



Chapter 4. Introduction


4.1 Definition Of Market Segments


4.1.1 By Type


4.1.1.1 Strips


4.1.1.2 Glucose Meters


4.1.1.3 Lancets


4.1.1.4 Others


4.1.2 By Application


4.1.2.1 Type 2 Diabetes


4.1.2.2 Type 1 Diabetes


4.1.2.3 Others


4.2 Market Dynamics


4.2.1 Trend


4.2.1.1 Introduction Of Technologically Advanced Smbg Devices


4.2.2 Drivers


4.2.2.1 Favorable Health Insurance And Reimbursement Scenario


4.2.2.2 Increasing Awareness About Diabetes Care


4.2.2.3 Growing Obese Population


4.2.2.4 Surge In Geriatric Population


4.2.2.5 Increasing Prevalence Of Diabetes


4.2.2.6 Impact Analysis Of Drivers On Market Forecast


4.2.3 Restraints


4.2.3.1 Increasing Product Recalls


4.2.3.2 Increasing Adoption Of Cgm Devices Over Smbg Devices


4.2.3.3 Impact Analysis Of Restraints On Market Forecast


4.2.4 Opportunities


4.2.4.1 Growing Adoption Of Home Healthcare Devices


4.3 Porter's Five Forces Analysis


4.3.1 Bargaining Power Of Buyers


4.3.2 Bargaining Power Of Suppliers


4.3.3 Intensity Of Rivalry


4.3.4 Threat Of New Entrants


4.3.5 Threat Of Substitutes



Chapter 5. Global Market Size And Forecast


5.1 By Type


5.2 By Application


5.3 By Region



Chapter 6. North America Market Size And Forecast


6.1 By Type


6.2 By Application


6.3 By Country


6.3.1 U.S. Smbg Devices Market


6.3.1.1 By Type


6.3.1.2 By Application


6.3.2 Canada Smbg Devices Market


6.3.2.1 By Type


6.3.2.2 By Application

Chapter 7. Europe Market Size And Forecast


7.1 By Type


7.2 By Application


7.3 By Country


7.3.1 Germany Smbg Devices Market


7.3.1.1 By Type


7.3.1.2 By Application


7.3.2 France Smbg Devices Market


7.3.2.1 By Type


7.3.2.2 By Application


7.3.3 U.K. Smbg Devices Market


7.3.3.1 By Type


7.3.3.2 By Application


7.3.4 Italy Smbg Devices Market


7.3.4.1 By Type


7.3.4.2 By Application


7.3.5 Spain Smbg Devices Market


7.3.5.1 By Type


7.3.5.2 By Application


7.3.6 Russia Smbg Devices Market


7.3.6.1 By Type


7.3.6.2 By Application



Chapter 8. Apac Market Size And Forecast


8.1 By Type


8.2 By Application


8.3 By Country


8.3.1 Japan Smbg Devices Market


8.3.1.1 By Type


8.3.1.2 By Application


8.3.2 China Smbg Devices Market


8.3.2.1 By Type


8.3.2.2 By Application


8.3.3 India Smbg Devices Market


8.3.3.1 By Type


8.3.3.2 By Application


8.3.4 Australia Smbg Devices Market


8.3.4.1 By Type


8.3.4.2 By Application



Chapter 9. Latam Market Size And Forecast


9.1 By Type


9.2 By Application


9.3 By Country


9.3.1 Brazil Smbg Devices Market


9.3.1.1 By Type


9.3.1.2 By Application


9.3.2 Mexico Smbg Devices Market


9.3.2.1 By Type


9.3.2.2 By Application



Chapter 10. Mea Market Size And Forecast


10.1 By Type


10.2 By Application



Chapter 11. Competitive Landscape


11.1 Product Benchmarking Of Key Players


11.2 Global Strategic Developments Of Key Players


11.2.1 Product Launches/Approvals


11.2.2 Other Developments



Chapter 12. Company Profiles


12.1 Johnson & Johnson


12.1.1 Business Overview


12.1.2 Product And Service Offerings


12.1.3 Key Financial Summary


12.2 Sinocare Inc.


12.2.1 Business Overview


12.2.2 Product And Service Offerings


12.3 Arkray Inc.


12.3.1 Business Overview


12.3.2 Product And Service Offerings


12.4 Nova Biomedical


12.4.1 Business Overview


12.4.2 Product And Service Offerings


12.5 Bionime Corporation


12.5.1 Business Overview


12.5.2 Product And Service Offerings


12.6 Medtronic Plc


12.6.1 Business Overview


12.6.2 Product And Service Offerings


12.6.3 Key Financial Summary


12.7 B. Braun Melsungen AG


12.7.1 Business Overview


12.7.2 Product And Service Offerings


12.7.3 Key Financial Summary


12.8 Abbott Laboratories


12.8.1 Business Overview


12.8.2 Product And Service Offerings


12.8.3 Key Financial Summary


12.9 Bayer AG


12.9.1 Business Overview


12.9.2 Product And Service Offerings


12.9.3 Key Financial Summary



For more information about this report visit

https://www.researchandmarkets.com/research/bbkq7b/selfmonitoring?w=5
Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/self-monitoring-blood-glucose-devices-worldwide-trends-drivers-restraints-and-opportunities-to-2023-300689266.html

SOURCE Research and Markets

View Comments and Join the Discussion!